Rodriguez G, McClatchy J, Campbell P
Infect Immun. 1974; 10(5):1163-9.
PMID: 16558105
PMC: 423077.
DOI: 10.1128/iai.10.5.1163-1169.1974.
Hahn H
Infect Immun. 1974; 10(5):1105-9.
PMID: 16558097
PMC: 423069.
DOI: 10.1128/iai.10.5.1105-1109.1974.
Kazar J, Gillmore J, GORDON F
Infect Immun. 1971; 3(6):825-32.
PMID: 16558062
PMC: 416245.
DOI: 10.1128/iai.3.6.825-832.1971.
Kazar J, Krautwurst P, GORDON F
Infect Immun. 1971; 3(6):819-24.
PMID: 16558061
PMC: 416244.
DOI: 10.1128/iai.3.6.819-824.1971.
BERRY L, Smythe D, Colwell L, Schoengold R, Actor P
Infect Immun. 1971; 3(3):444-8.
PMID: 16557994
PMC: 416172.
DOI: 10.1128/iai.3.3.444-448.1971.
Mouse Resistance Against Foot-and-Mouth Disease Virus Induced by Injections of Pyran.
Richmond J
Infect Immun. 1971; 3(2):249-53.
PMID: 16557961
PMC: 416139.
DOI: 10.1128/iai.3.2.249-253.1971.
Interferon production in mixed lymphocyte cell cultures.
Gifford G, Tibor A, Peavy D
Infect Immun. 1971; 3(1):164-6.
PMID: 16557935
PMC: 416123.
DOI: 10.1128/iai.3.1.164-166.1971.
Effects of an interferon inducer, poly I:C, on acute ocular infection produced by intracameral inoculation of Toxoplasma gondii.
Oh J, OConnor G
Infect Immun. 1971; 4(4):407-10.
PMID: 5154888
PMC: 416322.
DOI: 10.1128/iai.4.4.407-410.1971.
Ultrastructural changes in chick cerebellum induced by polyinosinic polycytidylic acid.
Yu M, Young P, Yu W
Am J Pathol. 1971; 64(2):305-20.
PMID: 5142269
PMC: 2047580.
Neutralization of the phagocytosis-enhancing activity of interferon preparations by anti-interferon serum.
Donahoe R, Huang K
Infect Immun. 1973; 7(3):501-3.
PMID: 4713697
PMC: 422709.
DOI: 10.1128/iai.7.3.501-503.1973.
Serotypic heterogeneity in isolates of human genital T-mycoplasmas.
Lin J, KASS E
Infect Immun. 1973; 7(3):499-500.
PMID: 4713696
PMC: 422708.
DOI: 10.1128/iai.7.3.499-500.1973.
Vaccines and cell-mediated immunity.
Collins F
Bacteriol Rev. 1974; 38(4):371-402.
PMID: 4613342
PMC: 413869.
DOI: 10.1128/br.38.4.371-402.1974.
Nonspecific protective action against Vibrio cholerae of SK&F 42319, a ribonucleic acid obtained from bacteriophage-infected Escherichia coli.
Actor P, Pitkin D, Goore M, BERRY L
Infect Immun. 1972; 6(5):886-8.
PMID: 4564788
PMC: 422626.
DOI: 10.1128/iai.6.5.886-888.1972.
Suppression of the intracellular growth of Shigella flexneri in cell cultures by interferon preparations and polyinosinic-polycytidylic acid.
Gober L, Friedman-Kien A, Havell E, Vilcek J
Infect Immun. 1972; 5(3):370-6.
PMID: 4564562
PMC: 422377.
DOI: 10.1128/iai.5.3.370-376.1972.
Purification of immunogenically active ribonucleic acid preparations of Salmonella typhimurium: molecular-sieve and anion-exchange chromatography.
Venneman M
Infect Immun. 1972; 5(3):269-82.
PMID: 4564556
PMC: 422361.
DOI: 10.1128/iai.5.3.269-282.1972.
Poly I-poly C and endotoxins share immunosuppressive properties and increase the toxicity of alpha-amanitin and hexobarbital.
FLOERSHEIM G, Szeszak J
Agents Actions. 1971; 2(3):150-5.
PMID: 4362164
DOI: 10.1007/BF01966754.
Protection of rabbits against local vaccinia virus infection by Brucella abortus and polyacrylic acid in the absence of systemic interferon production.
De Clercq E, DE SOMER P
Infect Immun. 1973; 8(4):669-73.
PMID: 4355140
PMC: 422908.
DOI: 10.1128/iai.8.4.669-673.1973.
Increased toxicity of double-stranded ribonucleic acid in virus-infected animals.
De Clercq E, Stewart 2nd W, DE SOMER P
Infect Immun. 1973; 7(2):167-72.
PMID: 4348963
PMC: 422655.
DOI: 10.1128/iai.7.2.167-172.1973.
Enhancement of phagocytosis by interferon-containing preparations.
Huang K, Donahoe R, GORDON F, DRESSLER H
Infect Immun. 1971; 4(5):581-8.
PMID: 4343410
PMC: 416356.
DOI: 10.1128/iai.4.5.581-588.1971.
The role of interferon in the protective effect of a synthetic double-stranded polyribonucleotide against intranasal vesicular stomatitis virus challenge in mice.
De Clercq E, Nuwer M, Merigan T
J Clin Invest. 1970; 49(8):1565-77.
PMID: 4317283
PMC: 322636.
DOI: 10.1172/JCI106374.
